Examination of antimicrobial activity of selected non-antibiotic products

Acta Poloniae Pharmaceutica - Drug Research

Volumn 67, Issue 6, 2010, Pages 733-736

  Kruszewska, Hanna ^a   Zarȩba, Tomasz ^a   Tyski, Stefan ^a,b  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Antimicrobial activity; Candida albicans; Drugs; Escherichia coli; Non antibiotics; Pseudomonas aeruginosa; Staphylococcus aureus

Indexed keywords

'TULIP'; AESCUVEN FORTE; ALLOPURINOL; AMPHOCHOL; ANESTELOC; ATORVASTATIN; ATORVOX; ATORWASTATYNA; AZATHIOPRINE; BIOPRAZOL; BISOGAMMA; BISOPROLOL FUMARATE; BROMHEXINE; CAPTOPRIL; CARBAMAZEPINE; CARDONIT; CHLORAZEPAM; CIRCULAT; CLOPROSTENOL; CLORANXEN; CURACNE; CYTISINE; DARTELIN; DEPRIM; DESOGESTREL; DIOSMIN; EFFOX; EMLA; EPIRAL; FLAMEXIN; FLEGAMINA; FLUVOXAMINE; FLUVOXAMINE MALEATE; GABAPENTIN; GINJAL; GINKOFAR; HESPERIDIN; HYDROCORTISONE; INDAPAMIDE; ISOSORBIDE; ISOSORBIDE MONONITRATE; ISOTRETINOIN; KETOPROFEN; LAMOTRIGINE; LEVOTHYROXINE SODIUM; LEXARPO; LISIPROL; LOSARTIC; MERCAPTOPURINE; METEOSPASMYL; METFOGAMMA; METFORMIN; MOBEMID; NEFRECIL; NEOPANCREATINUM; NERVOMIX; NEUROLIPON; NICERIN; NOAX; NOLVADOX; OMEPRAZOLE; OSELTAMIVIR; OTREX; PADMA; PANTOPRAZOLE; PANTOTHENATE CALCIUM; PENTOXIFYLLINE; PERNAZINUM; PIRAMIL; PIROXICAM; PREDNISONE; PREMORIN; PROURSAN; RECALIN; RIBAVIRIN; RILUTEC; SALAZOSULFAPYRIDINE; SEROFLURAN; SIMVAGAMMA; SOTRET; STAVERAN; TACROLIMUS; TIZANIDINE; TORAMIDE; TRAMADOL; TRIMEBUTINE; TRIMEBUTINE MALEATE; UNCLASSIFIED DRUG; UNINDEXED DRUG; UROSAL; VIBOLEX; VITAMIN B COMPLEX; WARFIN; ZOKARDIS;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG INDUSTRY; DRUG MANUFACTURE; ESCHERICHIA COLI; GROWTH INHIBITION; MICROBIAL GROWTH; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS; CANDIDA ALBICANS; DISK DIFFUSION ANTIMICROBIAL TESTS; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 78049305322     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Kristiansen J.E.: ASM NEWS 57, 135 (1991).
2. Williams J.D.: J. Antimicrob. Chemother. 35, 721 (1995).
3. Tyski S.: Acta Pol. Pharm. Drug Res. 66, 401 (2003).
4. Guttmann P., Ehrlich, P.: Berliner Klin. Wochenschr. 39, 953 (1891).
5. Hendricks O., Butterworth TS., Kristiansen JE.: Int. J. Antimicrob. Agents 22, 242 (2003).
6. Molnar J., Ren, J., Kristiansen, J. E.: Antonie van Leeuwenhoek 62, 315 (1992).
7. Kruszewska H., Zarȩba T., Tyski S.: Acta Pol. Pharm. Drug Res. 57 Supl., 117, (2000).
8. Kruszewska H., Zarȩba T., Tyski S.: Acta Pol. Pharm. Drug Res. 59, 436, (2002).
9. Kruszewska H., Zarȩba T., Tyski S.: Acta Pol. Pharm. Drug Res. 61 Supl., 436, (2004).
10. Kruszewska H., Zarȩba T., Tyski S.: Acta Pol. Pharm. Drug Res. 63, 457, (2006).
11. Kruszewska H., Zarȩba T., Tyski S., Scientific Review in Pharmacy (Polish), No. 2, 19 (2008).
12. Kruszewska H., Zarȩba T., Tyski S., Acta Pol. Pharm. Drug Res. 65, 779 (2008).
13. Amaral L., Kristiansen, J. E., Lorian, V.: J. Antimicrob. Chemother. 30, 556 (1992).
14. Chen M., Jensen B., Zhai L., Colding H., Kristiansen JE.: Int. J. Antimicrob. Agents 19, 195 (2002).
15. Martins M., Dastidar S.G., Fanning S., Kristiansen J.E., Molnar J., Pages J., Schelz Z. et al.: Int. J. Antimicrob. Agents 31, 198 (2008).
16. European Pharmacopoeia - 6 edn. + supplements, Council of Europe (COE) - European Directorate for the Quality of Medicines (EDQM), Strasbourg 2008-2010.
17. Clonts L.: Microbial Limit and Bioburden Tests: Validation approaches and global requirements, Interpharm Press Inc., Buffalo Grove 1998.
18. Podlewski J.K., Chwalibogowska-Podlewska A.: Drugs of modern therapy (Polish), 17 edn. Split Trading, Warszawa 2005.